| Primary |
| Eczema |
45.5% |
| Dermatitis Atopic |
17.2% |
| Vitiligo |
6.6% |
| Dermatitis |
6.3% |
| Rash |
3.6% |
| Product Used For Unknown Indication |
3.3% |
| Hodgkin's Disease |
2.0% |
| Oral Disorder |
1.6% |
| Psoriasis |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Pruritus |
1.5% |
| Alopecia |
1.3% |
| Rosacea |
1.3% |
| Hypersensitivity |
1.2% |
| Seborrhoeic Dermatitis |
1.2% |
| Hypertension |
1.1% |
| Pain |
1.0% |
| Chemotherapy |
0.8% |
| Erythema |
0.8% |
| Hypothyroidism |
0.8% |
|
| Weight Decreased |
17.1% |
| Lymphoma |
9.1% |
| Hodgkin's Disease |
6.4% |
| Swelling |
5.9% |
| Vomiting |
5.9% |
| Wound Infection |
5.6% |
| Weight Increased |
5.3% |
| Vaginal Haemorrhage |
4.8% |
| Non-hodgkin's Lymphoma |
4.5% |
| Urticaria |
3.7% |
| Pyrexia |
3.5% |
| Upper Respiratory Tract Infection |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| White Blood Cell Count Increased |
3.5% |
| Acute Lymphocytic Leukaemia |
3.2% |
| Surgery |
3.2% |
| Injury |
2.9% |
| Neoplasm Malignant |
2.9% |
| Pneumonia |
2.7% |
| Urinary Tract Infection |
2.7% |
|
| Secondary |
| Eczema |
40.5% |
| Vitiligo |
13.8% |
| Dermatitis Atopic |
12.1% |
| Dermatitis |
8.5% |
| Drug Use For Unknown Indication |
5.7% |
| Hypersensitivity |
2.4% |
| Hypertension |
2.4% |
| Cerebral Disorder |
1.6% |
| Diabetes Mellitus |
1.6% |
| Erythema |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Pruritus Generalised |
1.2% |
| Psoriasis |
1.2% |
| Rash Macular |
1.2% |
| Seborrhoeic Dermatitis |
1.2% |
| Acne |
0.8% |
| Hypothyroidism |
0.8% |
| Muscle Spasticity |
0.8% |
| Off Label Use |
0.8% |
| Osteoporosis |
0.8% |
|
| Weight Decreased |
17.8% |
| Wheezing |
11.1% |
| White Blood Cell Count Decreased |
8.9% |
| Hodgkin's Disease |
7.8% |
| Basal Cell Carcinoma |
6.7% |
| Small Intestine Carcinoma |
5.6% |
| Non-hodgkin's Lymphoma |
4.4% |
| Respiratory Distress |
4.4% |
| Wound Infection |
4.4% |
| Breast Cancer |
3.3% |
| Breast Cancer Female |
3.3% |
| Positron Emission Tomogram Abnormal |
3.3% |
| Road Traffic Accident |
3.3% |
| Accidental Exposure |
2.2% |
| B-cell Lymphoma |
2.2% |
| Depression |
2.2% |
| Injury |
2.2% |
| Lung Neoplasm Malignant |
2.2% |
| Lymphadenopathy |
2.2% |
| Lymphoma |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.2% |
| Acne |
8.0% |
| Gastrooesophageal Reflux Disease |
7.1% |
| Eczema |
6.2% |
| Drug Use For Unknown Indication |
5.2% |
| Psoriasis |
5.2% |
| Pain |
4.9% |
| Asthma |
4.4% |
| Rash |
4.4% |
| Depression |
4.3% |
| Anxiety |
3.8% |
| Metastases To Bone |
3.5% |
| Medical Diet |
3.0% |
| Non-small Cell Lung Cancer |
3.0% |
| Sinusitis |
3.0% |
| Constipation |
2.7% |
| Inflammatory Bowel Disease |
2.5% |
| Insomnia |
2.3% |
| Prophylaxis |
2.3% |
| Contraception |
2.2% |
|
| Weight Decreased |
15.2% |
| Vomiting |
11.4% |
| Ebstein's Anomaly |
7.6% |
| Weight Increased |
6.8% |
| Wound Drainage |
6.8% |
| Electrocardiogram Qt Prolonged |
5.3% |
| Jaundice |
5.3% |
| Pyrexia |
5.3% |
| Rash |
4.5% |
| Pruritus |
3.8% |
| Psoriasis |
3.8% |
| Thrombocytopenia |
3.8% |
| Oedema Peripheral |
3.0% |
| Status Asthmaticus |
3.0% |
| Suicidal Ideation |
3.0% |
| Abortion Spontaneous |
2.3% |
| Back Pain |
2.3% |
| Dizziness |
2.3% |
| Drug Ineffective |
2.3% |
| Lung Infection |
2.3% |
|
| Interacting |
| Dermatitis Atopic |
47.1% |
| Eczema |
23.5% |
| Neurodermatitis |
17.6% |
| Product Used For Unknown Indication |
11.8% |
|
| Otitis Media Acute |
33.3% |
| Squamous Cell Carcinoma |
33.3% |
| Wrist Fracture |
33.3% |
|
